#spatial-transcriptomics

[ follow ]
#patent-infringement #10x-genomics #illumina #prognosys-biosciences #brain-mapping #neuroanatomy
fromIPWatchdog.com | Patents & Intellectual Property Law
10 hours ago

10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents

On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, Inc. in the United States District Court for the District of Delaware, asserting that Illumina's spatial technology products infringed on patents covering technology for spatial transcriptomics, which allows researchers to study gene activity within a cell's tissue. U.S. Patent Nos. 11,008,607, 11,549,138, 12,234,505, and 12,297,487 are owned by Prognosys Biosciences and have significant applications in cancer research, neuroscience and immunology.
Science
Science
fromNature
3 months ago

A mouse brain stereotaxic topographic atlas with isotropic 1-m resolution - Nature

Brain stereotaxic atlases are crucial but traditional 2D methods impede accurate 3D brain mapping.
Roam Research
fromNews Center
4 months ago

New 'Molecular GPS' Will Fast-Track Drug Discovery - News Center

Northwestern University's SOAR will accelerate early-stage drug development by enabling better understanding of diseases and prioritizing potential treatments.
[ Load more ]